Saturday 17 October 2026
Export NVOS’s income statement to Excel — free account
Novo Integrated Sciences, Inc.
NVOS Healthcare Medical Care Facilities
Novo Integrated Sciences, Inc.’s revenue for fiscal 2024 (year ended August 2024) was $13.3 million, up 5.75% from fiscal 2023. Revenue growth for five consecutive years.
0.00
0.00
NaN
Follow NVOS
| Aug '16 | Dec '16 | Aug '17 | Aug '18 | Aug '19 | Aug '20 | Aug '21 | Aug '22 | Aug '23 | Aug '24 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 3 | 3 | 5 | 3 | 3 | 5 | 3 |
P/E ratio |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
45.99 | — | 29.38 | 269.78 | 84.82 | 8.73 | 0.99 | (2.28) | (2.43) | (4.39) |
P/S ratio |
0.00 | — | 62.48 | 233.37 | 85.34 | 11.72 | 4.85 | 4.13 | 1.13 | 0.39 |
P/FCF ratio |
1,059.09 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(26.66) | — | (6.71) | (10.96) | 2.87 | 3.32 | 1.24 | (8.52) | (6.08) | (11.54) |
P/Operating CF |
(2,426.02) | — | (657.45) | (21,964.97) | (2,760.37) | (5,906.15) | (60.48) | 71.78 | (62.20) | (9.58) |
Beneish M-Score |
— | — | (2.33) | (3.30) | (1.56) | (3.10) | (2.85) | (5.94) | (3.57) | (4.29) |
P/B ratio |
0.00 | — | 0.00 | 12,012.09 | 31.48 | 3.12 | 1.03 | 2.20 | 0.58 | 0.36 |
Price to Tangible BV |
0.00 | — | 0.00 | 0.00 | 313.79 | 39.87 | 19.73 | 0.00 | 20.39 | 0.00 |
EV/Sales |
0.00 | — | 63.53 | 233.97 | 85.38 | 11.59 | 5.10 | 4.49 | 1.20 | 0.41 |
EV/EBITDA |
5,949.97 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
681.19 | — | (514.61) | (2,226.84) | (978.23) | (206.26) | (46.27) | (8.96) | (6.72) | (1.08) |
EV/FCF |
1,104.35 | — | (495.36) | (1,869.53) | (865.04) | (198.74) | (36.79) | (8.68) | (6.58) | (1.06) |
Quick Ratio |
0.16 | 2.76 | 0.79 | 0.72 | 1.27 | 1.58 | 1.25 | 0.30 | 0.37 | 0.27 |
Current Ratio |
0.26 | 2.85 | 0.85 | 0.77 | 1.35 | 1.65 | 1.32 | 0.41 | 0.56 | 0.37 |
Net Debt/EBITDA |
24.58 | 0.33 | (80.47) | (1.37) | (0.79) | 0.37 | (0.88) | (0.57) | (0.56) | (0.18) |
Debt/Assets |
169.14% | 0.00% | 100.50% | 57.40% | 8.15% | 2.93% | 17.14% | 27.62% | 3.54% | 3.33% |
Debt/Equity |
(0.69) | 0.00 | (1.29) | 15.76 | 0.10 | 0.04 | 0.24 | 0.51 | 0.05 | 0.07 |
Asset Turnover |
4.92 | 0.00 | 2.85 | 1.73 | 0.51 | 0.23 | 0.19 | 0.23 | 0.33 | 0.39 |
Operating CF/Net income |
(0.30) | 0.67 | 1.10 | 0.44 | 2.10 | 0.09 | 0.23 | 0.18 | 0.17 | 0.31 |
Capex/Depreciation |
(0.76) | — | (0.56) | (2.43) | (1.11) | (0.01) | (0.15) | (0.02) | (0.01) | 0.00 |
Interest Coverage |
0.23 | — | (0.20) | (2.78) | (3.54) | (27.20) | (26.51) | (15.70) | (23.72) | (15.44) |
| 9.63% | 4.69% | 34.85% | 102.44% | (3.05%) | (17.84%) | (12.16%) | (99.77%) | (56.78%) | (82.67%) | |
| (23.33%) | (11.14%) | (26.45%) | (41.10%) | (2.12%) | (14.53%) | (9.17%) | (63.89%) | (34.58%) | (47.76%) | |
ROIC |
0.00% | 0.00% | 0.00% | (44.19%) | (1.88%) | (9.33%) | (5.93%) | (50.20%) | (21.09%) | (42.44%) |
Return on Tangible Assets |
4.81% | (453.02%) | 230.10% | 559.00% | (26.47%) | (239.98%) | (51.05%) | 1,292.11% | (705.46%) | 398.81% |
Average Days of Receivables |
77.35 | — | 68.80 | 71.05 | 68.36 | 94.50 | 89.53 | 65.39 | 73.12 | 86.54 |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
33.24% | — | 38.81% | 56.13% | 43.09% | 92.76% | 87.02% | 122.55% | 107.43% | 105.73% |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.07 | 0.13 | 0.71 | 0.77 | 0.67 | 0.65 | 0.67 | 0.62 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 7.51% | 9.41% | 11.33% | 3.82% | 8.99% |
Graham Net Nets |
(0.07) | — | (0.01) | 0.00 | 0.00 | (0.02) | (0.16) | (0.27) | (0.47) | (2.32) |
Graham Number |
0.00 | — | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(0.10%) | — | (0.15%) | (0.10%) | (0.05%) | (5.34%) | (10.60%) | (67.87%) | (96.69%) | (300.00%) |
Free Cash Flow Yield |
0.09% | — | (0.21%) | (0.05%) | (0.12%) | (0.50%) | (2.86%) | (12.52%) | (16.09%) | (97.99%) |
Revenue per Share |
0.43 | 0.00 | 0.45 | 0.43 | 0.43 | 3.41 | 3.76 | 4.03 | 1.24 | 0.74 |
Operating CF per Share |
0.01 | (0.05) | (0.05) | (0.04) | (0.04) | (0.19) | (0.41) | (2.02) | (0.22) | (0.28) |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | 0.00 | (0.01) | (0.10) | (0.07) | 0.00 | 0.00 |
Free Cash Flow per Share |
0.00 | (0.05) | (0.05) | (0.05) | (0.04) | (0.20) | (0.52) | (2.08) | (0.23) | (0.28) |
Cash per Share |
0.01 | 0.02 | 0.11 | 0.03 | 0.10 | 0.90 | 3.35 | 0.75 | 0.04 | 0.05 |
Shareholders Equity per Share |
(0.42) | 0.02 | (0.24) | 0.01 | 1.18 | 12.84 | 17.68 | 7.57 | 2.41 | 0.81 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.42) | 0.02 | (0.24) | 0.01 | 1.18 | 12.84 | 17.68 | 7.57 | 2.41 | 0.81 |
Free Cash Flow |
0.05 | (0.11) | (0.85) | (1.11) | (0.93) | (0.45) | (1.28) | (6.07) | (2.29) | (5.07) |
Working Capital |
(7.40) | 0.04 | (0.62) | (0.78) | 1.07 | 1.69 | 2.67 | (8.34) | (3.52) | (9.16) |
Capital Expenditures |
(0.05) | — | (0.04) | (0.18) | (0.11) | (0.01) | (0.26) | (0.19) | (0.05) | 0.00 |
Net Current Asset Value |
(7.41) | 0.04 | (6.15) | (2.00) | (2.63) | (1.52) | (7.02) | (13.09) | (6.68) | (12.11) |
EV/EBIT |
5,949.97 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.01 | — | 0.00 | 0.02 | 0.01 | 0.00 | 0.03 | 0.02 | 0.00 | 0.00 |
Price to Operating Income |
5,706.09 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.23 | — | 0.22 | 0.18 | 0.24 | 4.09 | 0.28 | 1.55 | 1.31 | 1.73 |
Cash ROIC |
(2.22%) | (104.97%) | (26.95%) | (31.17%) | (3.07%) | (1.39%) | (2.04%) | (17.10%) | (8.76%) | (30.70%) |
Accounts Receivable Turnover |
4.75 | — | 5.27 | 5.50 | 5.39 | 4.14 | 4.31 | 5.35 | 5.44 | 4.69 |
Accounts Payable Turnover |
4.56 | 0.00 | 5.79 | 3.63 | 4.81 | 4.73 | 4.70 | 4.27 | 2.87 | 2.24 |
Inventory Turnover |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.39 | 7.67 | 7.17 |
Average Days of Payables |
159.06 | 0.00 | 124.70 | 87.23 | 70.79 | 67.17 | 96.52 | 94.70 | 168.33 | 156.39 |
Days of Inventory on Hand |
0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 22.60 | 46.24 | 53.03 | 48.37 |
Average Receivables |
1.51 | — | 1.51 | 1.62 | 1.75 | 1.90 | 2.16 | 2.19 | 2.31 | 2.84 |
Average Payables |
1.02 | 1.03 | 0.86 | 1.51 | 1.23 | 1.01 | 1.17 | 1.63 | 2.66 | 3.37 |
Average Inventory |
— | — | — | — | — | — | — | 0.61 | 0.99 | 1.05 |
Average Assets |
1.46 | 1.48 | 2.79 | 5.13 | 18.51 | 33.83 | 48.67 | 51.42 | 38.22 | 33.85 |
Average Common Equity |
(3.54) | (3.52) | (2.12) | (2.06) | 12.86 | 27.56 | 36.69 | 32.93 | 23.27 | 19.56 |
Columns are period end dates